Differentiation of C2D macrophage cells after adoptive transfer

Clinical and Vaccine Immunology

Volumn 15, Issue 2, 2008, Pages 243-252

  Potts, Betsey E ^a   Hart, Marcia L ^a   Snyder, Laura L ^a   Boyle, Dan ^a   Mosier, Derek A ^a   Chapes, Stephen K ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; CELL SURFACE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; PHOSPHATE BUFFERED SALINE; PROTEIN C FMS; PROTEIN F4/80; PROTEIN GR 1; PROTEIN LY 6C; PROTEIN MAC 2; CD2 ANTIGEN; CHEMOKINE RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; DIFFERENTIATION ANTIGEN; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; RECIPIENT; SIGNAL TRANSDUCTION; SPLEEN; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL LINE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD2; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL LINE; CELL MEMBRANE; INTERFERON TYPE II; LUNG; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED C57BL; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, CHEMOKINE; SPLEEN;

EID: 40449119398     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00328-07     Document Type: Article

References (75)

1. Ammon, C., S. P. Meyer, L. Schwarzfischer, S. W. Krause, R. Andreesen, and M. Kreutz. 2000. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100:364-369.
2. Bashyam, H. 2007. IFNgamma: issuing macrophages a license to kill. J. Exp. Med. 204:3.
3. Beharka, A. A., J. W. Armstrong, and S. K. Chapes. 1998. Macrophage cell lines derived from major histocompatibility complex II-negative mice. In Vitro Cell. Dev. Biol. 34:499-507.
4. Bernier, T., T. Tschernig, R. Pabst, O. Macke, C. Steinmueller, and A. Emmendorffer. 2001. Effects of macrophage-CSF on pulmonary-macrophage repopulation after bone marrow transplantation. J. Leukoc. Biol. 70:39-45.
5. Beutler, B., and A. Poltorak. 2000. The search for Lps: 1993-1998. J. Endotox. Res. 6:269-293.
6. Blusse van Oud Alblas, A., H. Mattie, and R. van Furth. 1983. A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet. 16:211-219.
7. Brunstetter, M. A., J. A. Hardie, R. Schiff, J. P. Lewis, and C. E. Cross. 1971. The origin of pulmonary alveolar macrophages. Studies of stem cells using the Es-2 marker of mice. Arch. Intern. Med. 127:1064-1068.
8. Burke, B., S. Sumner, N. Maitland, and C. E. Lewis. 2002. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J. Leukoc. Biol. 72:417-428.
9. Cao, C., D. A. Lawrence, D. K. Strickland, and L. Zhang. 2005. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106:3234-3241.
10. Carr, I. 1973. The macrophage. A review of ultrastructure and function. Academic Press, Inc., New York, NY.
11. Cecil, A. A., and M. J. Klemsz. 2004. p38 activation through Toll-like receptors modulates IFN-gamma-induced expression of the Tap-1 gene only in macrophages. J. Leukoc. Biol. 75:560-568.
12. Chan, J., P. J. M. Leenen, I. Bertoncello, S. Nishikawa, and J. A. Hamilton. 1998. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92:1423-1431.
13. Cisneros, J. M., P. Munoz, J. Torre-Cisneros, M. Gurgui, M. J. Rodriguez-Hernandez, J. M. Aguado, A. Echaniz, et al. 1998. Pneumonia after heart transplantation: a multi-institutional study. Clin. Infect. Dis. 27:324-331.
14. Collins, R. G., U. Jung, M. Ramirez, D. C. Bullard, M. J. Hicks, C. W. Smith, K. Ley, and A. L. Beaudet. 2001. Dermal and pulmonary inflammatory disease in E-selectin and P-selectin double-null mice is reduced in triple-selectin-null mice. Blood 98:727-735.
15. Comber, P. G., M. D. Rossman, E. F. Rappaport, P. Chien, P. M. Hogarth, and A. D. Schreiber. 1989. Modulation of human mononuclear phagocyte Fc gamma RII mRNA and protein. Cell. Immunol. 124:292-307.
16. Dalpke, A. H., S. Eckerle, M. Frey, and K. Heeg. 2003. Triggering of Toll-like receptors modulates IFN-gamma signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling. Eur. J. Immunol. 33:1776-1787.
17. Delneste, Y., P. Charbonnier, N. Herbault, G. Magistrelli, G. Caron, J.-Y. Bonnefoy, and P. Jeannin. 2003. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 101:143-150.
18. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Che-mother. 40:1208-1213.
19. Dougherty, G. J., and W. H. McBride. 1984. Macrophage heterogeneity. J. Clin. Lab. Immunol. 14:1-11.
20. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
21. Emori, T. G., S. N. Banerjee, D. H. Culver, R. P. Gaynes, T. C. Horan, J. R. Edwards, W. R. Jarvis, J. S. Tolson, T. S. Henderson, W. J. Martone, et al. 1991. Nosocomial infections in elderly patients in the United States, 1986-1990. Am. J. Med. 91:289S-293S.
22. Ezekowitz, R. A., and S. Gordon. 1986. Interaction and regulation of macrophage receptors. Ciba Found. Symp. 118:127-136.
23. Faul, J. L., O. A. Akindipe, G. J. Berry, R. L. Doyle, and J. Theodore. 1999. Recurrent Pneumocystis carinii colonization in a heart-lung transplant recipient on long-term trimethoprim-sulfamethoxazole prophylaxis. J. Heart Lung Transplant. 18:384-387.
24. Ferret-Bernard, S., P. Sai, and J. M. Bach. 2004. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Immunol. Lett. 91:221-227.
25. File, T. M., Jr. 2002. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 34(Suppl. 1):S17-S26.
26. Frost, S. C., and M. D. Lane. 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260:2646-2652.
27. Gordon, S. 1996. The mononuclear phagocyte system and tissue homeostasis, p. 84-95. In D. J. Weatherall, J. G. G. Ledingham, and D. A. Warrell (ed.), Oxford textbook of medicine, vol. 1. Oxford University Press, Oxford, United Kingdom.
28. Gordon, S., P. R. Crocker, L. Morris, S. H. Lee, V. H. Perry, and D. A. Hume. 1986. Localization and function of tissue macrophages. Ciba Found. Symp. 118:54-67.
29. Gordon, S., I. Fraser, D. Nath, D. Hughes, and S. Clarke. 1992. Macrophages in tissues and in vitro. Curr. Opin. Immunol. 4:25-32.
30. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964.
31. Grusby, M. J., R. S. Johnson, V. E. Papaioannou, and L. H. Glimcher. 1991. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420.
32. Gusella, G. L., E. Ayroldi, I. Espinoza-Delgado, and L. Varesio. 1990. Lipopolysaccharide, but not IFN-gamma, down-regulates c-fms mRNA protooncogene expression in murine macrophages. J. Immunol. 144:3574- 3580.
33. Hart, M. L., D. A. Mosier, and S. K. Chapes. 2003. Toll-like receptor 4-positive macrophages protect mice from Pasteurella pneumotropica-induced pneumonia. Infect. Immun. 71:663-670.
34. Jayaram, Y., A. M. Buckle, and N. Hogg. 1989. The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma. Clin. Exp. Immunol. 75:414-420.
35. Johnson, C. R., D. Kitz, and J. R. Little. 1983. A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J. Immunol. Methods 65:319-332.
36. Jutila, M. A., F. G. Kroese, K. L. Jutila, A. M. Stall, S. Fiering, L. A. Herzenberg, E. L. Berg, and E. C. Butcher. 1988. Ly-6C is a monocyte/ macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18:1819-1826.
37. Kennedy, D. W., and J. L. Abkowitz. 1998. Mature monocytic cells enter tissues and engraft. Proc. Natl. Acad. Sci. USA 95:14944-14949.
38. Leenen, P. J., M. F. de Bruijn, J. S. Voerman, P. A. Campbell, and W. van Ewijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174:5-19.
39. Leenen, P. J., M. Melis, W. A. Slieker, and W. Van Ewijk. 1990. Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur. J. Immunol. 20:27-34.
40. Leenen, P. J., W. A. Slieker, M. Melis, and W. Van Ewijk. 1990. Murine macrophage precursor characterization. I. Production, phenotype and differentiation of macrophage precursor hybrids. Eur. J. Immunol. 20:15-25.
41. Leenen, P. J. M., and P. A. Campbell. 1993. Heterogeneity of mononuclear phagocytes. An interpretive review, p. 29-85. In M. A. Horton (ed.), Blood cell biochemistry, vol. 5. Plenum Press, New York, NY.
42. Lotz, M., C. Andrews, Jr., C. Korzelius, E. Lee, G. Steele, Jr., A. Clarke, and A. Mercurio. 1993. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neo-plastic progression of colon carcinoma. Proc. Natl. Acad. Sci. USA 90:3466-3470.
43. Makala, L. H., Y. Nishikawa, M. Mishima, N. Inoue, X. Xuan, H. Suzuki, K. Fujisaki, T. Mikami, and H. Nagasawa. 2002. Phenotype and function of murine peritoneal cavity macrophage derived-dendritic cells. J. Vet. Med. Sci. 64:813-820.
44. McKnight, A. J., and S. Gordon. 1998. Membrane molecules as differentiation antigens of murine macrophages. Adv. Immunol. 68:271-314.
45. McQualter, J. L., and C. C. Bernard. 2007. Multiple sclerosis: a battle between destruction and repair. J. Neurochem. 100:295-306.
46. Myers, M. J., N. Ghildyal, and L. B. Schook. 1995. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages. Immunology 85:318-324.
47. Naito, M., S. Umeda, T. Yamamoto, H. Moriyama, H. Umezu, G. Hasegawa, H. Usuda, L. Shultz, and K. Takahashi. 1996. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J. Leukoc. Biol. 59:133-138.
48. Nathan, C. F. 1983. Mechanisms of macrophage antimicrobial activity. Trans. R. Soc. Trop. Med. Hyg. 77:620-630.
49. Nibbering, P. H., P. C. Leijh, and R. van Furth. 1987. Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology 62:171-176.
50. Nishihara, K., R. F. Barth, N. Wilkie, J. C. Lang, Y. Oda, H. Kikuchi, M. P. Everson, and M. T. Lotze. 1995. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha. Cancer Gene Ther. 2:113-124.
51. Ozaki, H., T. Kawai, C. W. Shuttleworth, K. J. Won, T. Suzuki, K. Sato, H. Horiguchi, M. Hori, H. Karaki, S. Torihashi, S. M. Ward, and K. M. Sanders. 2004. Isolation and characterization of resident macrophages from the smooth muscle layers of murine small intestine. Neurogastroenterol. Motil. 16:39-51.
52. Pace, J. L., S. W. Russell, R. D. Schreiber, A. Altman, and D. H. Katz. 1983. Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc. Natl. Acad. Sci. USA 80:3782-3786.
53. Panlilio, A. L., D. H. Culver, R. P. Gaynes, S. Banerjee, T. S. Henderson, J. S. Tolson, and W. J. Martone. 1992. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect. Control Hosp. Epidemiol. 13:582-586.
54. 3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages. Infect. Immun. 55:2017-2020.
55. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615-625.
56. Rhodes, N. P., J. A. Hunt, and D. F. Williams. 1997. Macrophage subpopulation differentiation by stimulation with biomaterials. J. Biomed. Mater. Res. 37:481-488.
57. Rosen, H., and S. Gordon. 1990. Adoptive transfer of fluorescence-labeled cells shows that resident peritoneal macrophages are able to migrate into specialized lymphoid organs and inflammatory sites in the mouse. Eur. J. Immunol. 20:1251-1258.
58. Rosenow, E. C., III, W. R. Wilson, and F. R. Cockerill III. 1985. Pulmonary disease in the immunocompromised host. 1. Mayo Clin. Proc. 60:473-487.
59. Rutherford, M., A. Witsell, and L. Schook. 1993. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukoc. Biol. 53:602-618.
60. Sanders, P., and J. De Keyser. 2007. Janus faces of microglia in multiple sclerosis. Brain Res. Rev. 54:274-285.
61. Schreiber, R. D., A. Celada, and N. Buchmeier. 1986. The role of interferon-gamma in the induction of activated macrophages. Ann. Inst. Pasteur Immunol. 137C:203-206.
62. Shi, D., J. Das, and G. Das. 2006. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Cell Res. 16:70-74.
63. Silva, H. L., T. M. Strabelli, E. R. Cunha, S. F. Neres, L. F. Camargo, and D. E. Uip. 2000. Nosocomial coagulase negative staphylococci bacteremia: five year prospective data collection. Braz. J. Infect. Dis. 4:271-274.
64. Spoettl, T., M. Hausmann, K. Menzel, H. Piberger, H. Herfarth, J. Schoelmerich, F. Bataille, and G. Rogler. 2007. Role of soluble factors and three-dimensional culture in in vitro differentiation of intestinal macrophages. World J. Gastroenterol. 13:1032-1041.
65. Stout, R. D., and J. Suttles. 2004. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76: 509-513.
66. Tormey, V., J. Faul, C. Leonard, C. Burke, A. Dilmec, and L. Poulter. 1997. T-cell cytokines may control the balance of functionally distinct macrophage populations. Immunology 90:463-469.
67. Vairo, G., A. K. Royston, and J. A. Hamiltons. 1992. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide. J. Cell. Physiol. 151:630-641.
68. van Dissel, J., J. Stikkelbroeck, B. Michel, M. van den Barselaar, P. Leijh, and R. van Furth. 1987. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J. Immunol. 139:1673-1678.
69. Wan, H., and M. Dupasquier. 2005. Dendritic cells in vivo and in vitro. Cell. Mol. Immunol. 2:28-35.
70. Werner, K., A. Bitsch, S. Bunkowski, B. Hemmerlein, and W. Bruck. 2002. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions. Glia 40:121-129.
71. Wilson, W. R., F. R. Cockerill III, and E. C. Rosenow III. 1985. Pulmonary disease in the immunocompromised host (2). Mayo Clin. Proc. 60:610-631.
72. Wiltrout, R. H., M. J. Brunda, E. Gorelik, E. S. Peterson, J. J. Dunn, J. Leonhardt, L. Varesio, C. W. Reynolds, and H. T. Holden. 1983. Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents. J. Reticuloendothel. Soc. 34:253-269.
73. Wright, A. D., and S. K. Chapes. 1999. LPS sensitivity in recombinant mice lacking functional alleles at MHCII, LPS, and Nramp1 genes. J. Endotox. Res. 5:297-305.
74. Wu, M., S. Hussain, Y. H. He, R. Pasula, P. A. Smith, and W. J. Martin II. 2001. Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice. Proc. Natl. Acad. Sci. USA 98:14589-14594.
75. Wu, Q., Y. Feng, Y. Yang, Jingliu, W. Zhou, P. He, R. Zhou, X. Li, and J. Zou. 2004. Kinetics of the phenotype and function of murine peritoneal macrophages following acute inflammation. Cell. Mol. Immunol. 1:57-62.